• 1
    Saito K, Kawakami S, Fujii Y, Sakura M, Masuda H, Kihara K. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically. J Urol 2007;178: 22916
  • 2
    Akao J, Matsuyama H, Yamamoto Y et al. Clinical significance of lymphovascular invasion in upper urinary tract urothelial cancer. BJU Int 2008 May 15
  • 3
    Brausi MA, Gavioli M, De Luca G et al. Retroperitoneal lymph node dissection (RPLD) in conjunction with nephroureterectomy in the treatment of infiltrative transitional cell carcinoma (TCC) of the upper urinary tract: impact on survival. Eur Urol 2007; 52: 14148
  • 4
    Kondo T, Nakazawa H, Ito F, Hashimoto Y, Toma H, Tanabe K. Impact of the extent of regional lymphadenectomy on the survival of patients with urothelial carcinoma of the upper urinary tract. J Urol 2007; 178: 12127
  • 5
    Roscigno M, Cozzarini C, Bertini R et al. Prognostic value of lymph node dissection in patients with muscle-invasive transitional cell carcinoma of the upper urinary tract. Eur Urol 2008; 53: 794802
  • 6
    Lehmann J, Suttmann H, Kovac I et al. Transitional cell carcinoma of the ureter: prognostic factors influencing progression and survival. Eur Urol 2007; 51: 12818
  • 7
    Guinan P, Volgelzang NJ, Randazzo R et al. Renal pelvic transitional cell carcinoma: the role of the kidney in tumor-node-metastasis staging. Cancer 1992; 69: 17735
  • 8
    Wu CF, Pang ST, Chen CS, Chuang CK, Chen Y, Lin PY. The impact factors on prognosis of patients with pT3 upper urinary tract transitional cell carcinoma. J Urol 2007; 178: 44650
  • 9
    Kwak C, Lee SE, Jeong IG, Ku JH. Adjuvant systemic chemotherapy in the treatment of patients with invasive transitional cell carcinoma of the upper urinary tract. Urology 2006; 68: 537